Table 2.
Peptide/hormone | State of negative energy balance | Anorexia nervosa | Activity-based anorexia rodent model |
---|---|---|---|
AgRP | ↑92,93,130,178 | ↑221 | ↑↑178 |
NPY | ↑178 | ↑221 | ↑↑178 |
POMC | ↓87,104,178,203 | ↓236 | ↓178 |
beta-endorphins | ↑205 | ↑204,207 | ↑206 |
CART | Similar to POMC | Similar to POMC | ↓178 |
Orexin | =178 | ↑222 | ↑178 |
MCH | =178 | — | ↑178 |
CRH | Inconclusive | ↑237,238,239,240 | ↑67,178,234 |
Serotonin | ↓241 | ↓242 | ↓33 |
Dopamine | ↓75,77 | ↓ ↑ receptor density 243,244 |
↑33,245 |
Leptin | ↓246 | ↓43,44,45,46,47 | ↓21,178 |
Ghrelin | ↑52,53 | ↑54,55 | ↑56 |
CORT | ↑67 | ↑59,60,61,63 | ↑67 |
Effects of exogenously applied leptin | ↓ FI ↑ EE 87,101 |
Expected to ameliorate hyperactivity and depression247 | ↓ hyperactivity21,43,248 |
Effects of ghrelin | ↑ activity AgRP and orexin neurons92,93 | ↑ FI57 | ↑ hyperactivity56 |
Effects of CORT | ↑ activity AgRP and orexin neurons92,93 | — | — |
AgRP, agouti-related peptide; CART, cocaine- and amphetamine-regulated transcript; CORT, cortisol or corticosterone; CRH, corticotropin-releasing hormone; EE, energy expenditure; FI, food intake; MCH, melanin-concentrating hormone; NPY, neuropeptide Y; POMC, pro-opiomelanocortin. Studies were performed in rats, mice, or humans.